Skip to content

FEMY

Femasys Inc.

NASDAQ · Healthcare · Medical - Instruments & Supplies · US

$2.98
−2.61%
Ask drillr

Income statement

MetricTTM2025202420232022
Revenue
Total Revenue2.3M2.3M1.6M1.1M1.2M
Cost of Revenue1.1M872.4K544.9K380.1K441.9K
Gross Profit1.2M1.4M1.1M691.9K764.3K
Operating Expenses
R&D Expense6.5M7.6M8.2M7.2M5.8M
SG&A Expense12.2M11.1M10.4M7.5M6.0M
General & Admin Expense7.0M6.6M6.3M6.9M5.4M
Selling & Marketing Expense5.2M4.4M4.0M650.1K558.9K
Other Expenses133.8K342.0K297.3K483.5K561.2K
Total Operating Expenses18.8M19.0M18.9M15.2M12.4M
Cost and Expenses19.9M19.9M19.4M15.6M12.8M
Operating Income (EBIT)(17.6M)(17.6M)(17.8M)(14.5M)(11.6M)
Non-Operating
Interest Income135.1K101.8K582.4K431.0K228.2K
Interest Expense1.3M1.9M1.6M165.4K13.5K
Net Interest Income(1.2M)(1.8M)(1.0M)265.6K214.7K
Other Non-Op Income/Expense5.8M(1.0M)(1.0M)265.6K212.4K
Non-Operating Income (excl Interest)(7.1M)(853.2K)(582.4K)(431.0K)(225.9K)
EBT (Pre-Tax Income)(11.8M)(18.6M)(18.8M)(14.2M)(11.4M)
Income Tax Expense523.8K1.3K9.6K4.3K6.3K
Bottom Line
Net Income(12.3M)(18.6M)(18.8M)(14.2M)(11.4M)
Earnings from Cont. Ops(12.3M)(18.6M)(18.8M)(14.2M)(11.4M)
Earnings from Discont. Ops
Bottom Line Net Income(12.3M)(18.6M)(18.8M)(14.2M)(11.4M)
Per Share
Basic EPS($4.56)($9.40)($16.80)($18.60)($19.40)
Diluted EPS($4.57)($9.40)($16.80)($18.60)($19.40)
Revenue Per Share$0.68$1.16$1.46$1.39$2.04
Shares
Basic Shares Outstanding3.4M2.0M1.1M769219590208
Diluted Shares Outstanding3.4M2.0M1.1M769219590208
Profitability Metrics
EBITDA(9.8M)(15.9M)(16.3M)(13.2M)(10.5M)
D&A701.8K850.5K872.0K908.0K889.1K
EBIT(10.5M)(16.7M)(17.2M)(14.1M)(11.4M)

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026